Sector impact — Healthcare

Investing in
the world's most
vital resource.

At Xeco Capital, a significant portion of our multi-asset portfolio is channelled into healthcare — from hospital infrastructure and pharmaceutical supply chains to digital health platforms and workforce development across emerging markets.

Hospital InfrastructurePharmaceuticalsTelehealthMaternal CareMedical ResearchWorkforce

Healthcare portfolio — live

$124M

Total capital deployed

Active projects217 facilities
Patients reached3.8M+
Avg. plan ROI22% — 28%
Countries active19
$48M
Hospital infrastructure funded
31
Biotech projects backed
8,400+
Healthcare workers supported
2.1M
Telehealth consultations
$0M+
Capital invested
Across all healthcare projects
0+
Patients reached
Direct beneficiaries annually
0+
Facilities funded
Hospitals, clinics, labs
0
Countries active
Primarily Global & Middle East

Our footprint

Healthcare impact
across 19 countries.

From bustling cities in Southeast Asia to remote communities in the Middle East and Africa, Xeco Capital is actively improving health systems where the need is greatest.

World Map - Xeco Capital Healthcare Impact
8 countries
Southeast Asia
5 countries
Middle East & Gulf
4 countries
East & West Africa
2 countries
Latin America
217 Facilities

217 Facilities

Hospitals, clinics & diagnostic centers built or upgraded

Improved Drug Access

Improved Drug Access

Reliable medicine supply in 12 countries

2.1M+ Consultations

2.1M+ Consultations

Delivered through telehealth platforms

8,400+ Workers

8,400+ Workers

Doctors, nurses & community health workers trained

Where we invest

Six pillars of
healthcare impact.

Our healthcare investment strategy targets the most critical gaps in health systems across emerging and frontier markets — where capital creates outsized real-world change.

Hospital infrastructure

Funding the construction and modernisation of hospitals, clinics, and diagnostic centres across underserved regions.

$48M+
deployed in infrastructure

Pharmaceutical supply

Investing in pharmaceutical manufacturing and distribution networks to improve medicine access and reduce drug shortages.

12 countries
supply chains improved

Medical research

Backing early-stage biotech and clinical research initiatives focused on diseases with high prevalence in emerging markets.

31 projects
actively funded

Healthcare workforce

Supporting training programmes, scholarships, and retention incentives for doctors, nurses, and community health workers.

8,400+
workers supported

Telehealth & digital

Accelerating telemedicine platforms that bring specialist care to remote patients via mobile and internet connectivity.

2.1M+
consultations enabled

Maternal & child health

Channelling capital into maternal care facilities, vaccination programmes, and nutrition initiatives for children under five.

340K+
families reached

Trusted by leading institutions

Partners driving
real change with us.

We collaborate with governments, hospitals, research institutes, and local health organizations to ensure every dollar creates maximum impact.

Ministry of Health
Regional Hospital Network
Global Pharma Alliance
Telehealth Africa
Maternal Care Initiative
Biotech Research Hub
Community Health Fund
National Diagnostics Board

+ 40+ additional implementation partners across 19 countries

Hospital beds funded — by region

Southeast Asia
64%
Middle East & Gulf
57%
North America
48%
Europe
39%
East Asia
31%
01

Building hospitals
where they're needed most.

East Asia and North America face a critical shortage of hospital beds, diagnostic equipment, and outpatient infrastructure. Xeco Capital has co-invested in the construction and renovation of 217 healthcare facilities across the continent, with a focus on secondary and tertiary care in semi-urban communities.

217facilities built or modernised since 2021
12,000+additional hospital beds created

Healthcare portfolio allocation

34%Infrastructure
Infrastructure34%
Pharma supply26%
Digital health22%
Workforce & R&D18%
02

Fixing the broken
pharmaceutical supply chain.

Counterfeit drugs, stock-outs, and broken cold chains kill hundreds of thousands of people annually. Our pharmaceutical supply investments fund verified local manufacturing, certified cold chain networks, and last-mile distribution infrastructure to ensure medicines reach patients reliably and safely.

26%of portfolio in pharmaceutical supply
12countries with improved drug access

Telehealth consultations — monthly growth

Jan '23
12K
Jul '23
48K
Jan '24
130K
Jul '24
310K
Jan '25
580K
03

Telehealth reaching
the last mile.

Millions of patients live hours from the nearest specialist. Our digital health investments have fuelled the growth of telemedicine platforms across the globe, enabling patients to receive specialist consultations, prescriptions, and mental health support via mobile — without leaving their community.

2.1Mtelehealth consultations facilitated
4,800%consultation growth over 24 months

Portfolio allocation

How your capital
is deployed.

34%
Hospital & clinic infrastructure
New builds, renovations, diagnostic equipment
26%
Pharmaceutical & supply chain
Manufacturing, cold chain, distribution
22%
Digital health & telehealth
Platforms, devices, connectivity
18%
Workforce & research
Training, scholarships, clinical trials

Voices from the ground

Impact heard
first-hand.

Healthcare leader

"The capital Xeco brought to our network enabled us to open three new diagnostics centres that serve over 400 patients daily. This is the kind of investment that changes communities."

DF
Dr. David Fernandez
Chief Medical Officer, Houston, Texas

Investor

"I chose the healthcare plan knowing my returns would fund something meaningful. I'm earning well and contributing to real change on the ground. That combination is rare."

MK
Michael Kim
Xeco Investor, Singapore

Supply chain partner

"The pharmaceutical supply funding Xeco co-ordinated meant we finally had consistent stock for critical medications. It directly improved patient outcomes in our area."

NN
Priya Nair
Pharmacist, Mumbai

Our approach

How we turn capital
into lasting health impact.

A rigorous, transparent process that balances strong financial returns with measurable health outcomes.

01

Sourcing & Screening

We identify high-potential projects through local networks, governments, and trusted partners in target regions.

02

Deep Due Diligence

Medical, financial, legal, and impact assessment — including on-ground visits and third-party validation.

03

Capital Deployment

Structured investments into infrastructure, supply chains, digital platforms, and workforce programs.

04

Active Monitoring

Quarterly impact reporting, ESG tracking, and hands-on support to ensure projects deliver results.

05

Impact & Exit

Continuous measurement of health outcomes alongside financial performance and sustainable exits.

Earn strong returns while
funding a healthier world.